U.S., Jan. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07318662) titled 'Efficacy and Safety of HMAs Combined With Venetoclax Versus HMAs Alone in ND Int-and H-risk MDS or CMML' on Nov. 16, 2025.
Brief Summary: The aim of this study is to observe and analyze the clinical efficacy of Venetoclax+HMAs regimen in the treatment of newly diagnosed higher-risk MDS and CMML cases, and to compare the efficacy of venetoclax +HMAs regimen with that of HMAS regimen alone, in order to provide a normative scheme and basis for clinical use.
Study Start Date: Jan. 01, 2020
Study Type: OBSERVATIONAL
Condition:
MDS
CMML
Intervention:
DRUG: Venetoclax
Previous phase Ib studies have fully demonstrated that venetoclax ...